A content analysis of parents’ reflections on pathogenic and uncertain pediatric oncology germline sequencing results

• Published in: Familial cancer 2024-11, Vol.23 (4), p.551-561
• Main Authors: Howard Sharp, Katianne M., Clark, Mary Egan, Jurbergs, Niki, Ouma, Annastasia, Harrison, Lynn, Taylor, Leslie, Hamilton, Kayla, McGee, Rose B., Nuccio, Regina, Hines-Dowell, Stacy, Gattuso, Jami S., Pritchard, Michelle, Mandrell, Belinda, Tercyak, Kenneth P., Johnson, Liza-Marie, Nichols, Kim E.
• Format: Article
• Language: English
• Subjects: Adaptation, Psychological; Adolescent; Adult; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer Research; Child; Child, Preschool; Children; Content analysis; Emotions; Epidemiology; Female; Genetic counseling; Genetic Counseling - psychology; Genetic Predisposition to Disease; Genetic Testing; Genomic analysis; Germ-Line Mutation; Human Genetics; Humans; Male; Middle Aged; Neoplasms - genetics; Neoplasms - psychology; Original Article; Parents & parenting; Parents - psychology; Pediatrics; Uncertainty
• ISSN: 1389-9600; 1573-7292; 1573-7292
• DOI: 10.1007/s10689-024-00417-9

Germline genomic sequencing is increasingly integrated into pediatric cancer care, with pathogenic cancer-predisposing variants identified among 5–18% of affected children and variants of uncertain significance (VUS) in up to 70%. Given the potential medical implications for children and their families, parents’ psychosocial responses to learning results are important to understand. Parents of children with cancer who learned their children’s germline pathogenic or VUS results following paired tumor and germline genomic sequencing described their cognitive and affective responses to results in an open-ended write-in question after disclosure ( M  = 10 months post-disclosure; range = 1–28). Responses were coded and categorized using content analysis, then compared across results using chi-square and Fisher’s exact test. Parents of children with pathogenic ( n  = 9), VUS ( n  = 52), and pathogenic plus VUS results ( n  = 9) described negative emotions, positive reactions, mixed emotions (i.e., positive and negative emotions), and neutral reactions. Negative emotions were described significantly more frequently with pathogenic results than VUS only ( χ 2  = 5.19; p  = .02), with peace of mind and empowerment only described for those with VUS. Parents also described approach(es) to coping (e.g., faith, plan of action) and reactions specific to the uncertainty of VUS (e.g., disappointment at no explanation for cancer etiology). A subset with VUS described decreasing worry/distress with increased understanding of results, whereas others displayed misconceptions regarding VUS. Screening for emotional adjustment is warranted for parents of children with cancer receiving pathogenic germline results, and screening for understanding is warranted with VUS. Findings highlight the importance of pre-and posttest genetic counseling.